In its interim results for the fiscal year ending March 2027, MatsukiyoCocokara & Co. reported ordinary profit of ¥44,580 million, an improvement from the previous fiscal year. This exceeded the preliminary forecast of ¥41,500 million. The full-year ordinary profit forecast was left unchanged at ¥91,500 million.
In the interim results for the fiscal year ending March 2027 announced by MatsukiyoCocokara & Co. on 13 November, ordinary profit was ¥44,580 million, 7.4% above the company's preliminary forecast of ¥41,500 million. This showed that the company's interim earnings level was above market expectations.
The full-year ordinary profit forecast announced on the same day was left unchanged at ¥91,500 million, 2.7% below the IFIS consensus. The outlook through year-end therefore remains unchanged from the forecast provided at the time of this interim results announcement.
Related stocks including SUND, Cosmos Pharmaceutical and Yamada Holdings are also attracting attention. The information was provided by IFIS Japan.